Merck & Co. (MRK)
(Delayed Data from NYSE)
$131.19 USD
+0.31 (0.24%)
Updated May 17, 2024 04:00 PM ET
After-Market: $131.20 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 41 - 60 ( 394 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 91123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 9123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 82123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 81123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 8123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 9.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department